Deep nanoparticle protein corona plasma proteomics resolves a stage-specific peripheral signature of Alzheimer's disease
Negar MahmoudiiD, Bahareh GhaffariiD, Kenneth RogaleiD, Samuel CheesemaniD, Danilo RitziD, Alexander SchmidtiD, Liuchenxin Han, Qingling Li, Jared S. Deyarmin, Stephanie N. Samra, Dmitry LeshchineriD, Sachi HoribataiD, Christopher James FowleriD, Borzoo BonakdarpouriD, George PerryiD, Amir Ata SaeiiD, Colin Louis MastersiD, Babak BorhaniD, David R. NisbetiD, Morteza MahmoudiiD
Abstract
Structured AbstractO_ST_ABSINTRODUCTIONC_ST_ABSAlzheimers disease (AD) progresses over decades, yet plasma biomarkers that resolve disease stage rather than simply detect disease remain scarce. This distinction is clinically consequential because effective AD intervention depends on identifying patients before disease biology has progressed beyond a therapeutically responsive stage. METHODSWe used small-molecule-modulated protein corona proteomics to profile plasma from 90 individuals in the Australian Imaging, Biomarker and Lifestyle cohort, stratified by Centiloid (CL) A{beta}-amyloid burden (30 amyloid- negative, CL 100). We quantified 3,176 proteins and applied differential abundance and actual causality analyses to identify stage-specific and candidate causal proteins. RESULTSDifferential protein abundance was exclusively captured during the moderate-to-high AD transition, revealing a discrete proteomic "switch." The switch was marked by accumulation of the autophagy receptor CALCOCO1, together with coordinated depletion of the S100A8/S100A9 calprotectin complex and core erythroid-cytoskeletal network structural markers (e.g., SPTA1, SPTB, ANK1). Adhesion G protein-coupled receptor G6 (ADGRG6) showed a significant moderate positive monotonic association with absolute CL burden, providing a proportional molecular anchor for cumulative disease burden. Actual causality analysis identified COL6A2, FOXRED2, P3H1, PRR4, and GOLGA5 as candidate upstream drivers linking matrix remodeling, Golgi trafficking, and collagen processing to AD progression. DISCUSSIONThese findings suggest a candidate blood-accessible framework for staging AD by active disease biology, which, if replicated in independent cohorts, may have implications for therapeutic selection and mechanism-guided clinical trials. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=92 SRC="FIGDIR/small/740710v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@1ead718org.highwire.dtl.DTLVardef@cfa523org.highwire.dtl.DTLVardef@62a367org.highwire.dtl.DTLVardef@1d5c9a5_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid Mechanistic Bridging of an Alzheimer's Disease Plasma Protein Staging Panel Across Brain Proteomics Cohorts
Charles C. Kim, Meghan Kerrisk Campbell, … Peter Cimermančič·bioRxiv·Sep 4, 2026
- Interpretable Machine Learning Links Group-Specific Plasma Proteomics to Regional Structural Neuroimaging in Alzheimer's Disease
Hemshankar Laugi, Mohammadreza Hosseinzadehketilateh, … Xi Zhu·bioRxiv·Nov 4, 2026
- Proteomic Signatures of Neuropathological Alterations in Alzheimer's Disease: Insights from the Bio-Hermes Study
Hanjun Zhao, Taiyu Zhu, … Laura M. Winchester·bioRxiv·May 22, 2026
- Identification of Novel Biomarkers for Alzheimer's Disease and Related Dementias Using Unbiased Plasma Proteomics
Benjamin Lacar, Shadi Ferdosi, … Asim S. Siddiqui·bioRxiv·Jan 5, 2024
- Deep proteome analysis of plasma reveals novel biomarkers of mild cognitive impairment and Alzheimer's disease: A longitudinal study
Gurjeet Kaur, Anne Poljak, Perminder Singh Sachdev·bioRxiv·Jan 30, 2022
- Multi-Platform Proteomic Analysis of Alzheimer's Disease Cerebrospinal Fluid and Plasma Reveals Network Biomarkers Associated with Proteostasis and the Matrisome
Eric B. Dammer, Lingyan Ping, … Erik C. B. Johnson·Alzheimer s Research & TherapyPeer-reviewed·Nov 16, 2022